References
- Chen H, Jia WD, Li JS, et al (2011). Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Med Oncol, 1, 318-25.
- Dong JR, Guo N, Zhao JP, et al (2013). Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer. Asian Pac J Cancer Prev, 14, 7137-41. https://doi.org/10.7314/APJCP.2013.14.12.7137
- Duzlu M, Karamert R, Tutar H, et al (2015). Neutrophil-lymphocyte ratio findings and larynx carcinoma: a preliminary study in Turkey. Asian Pac J Cancer Prev, 16, 351-4. https://doi.org/10.7314/APJCP.2015.16.1.351
- Fujimoto N, Terlizzi J, Aho S, et al (2006). Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/proteininteractions. Exp Dermatol, 15, 300-7. https://doi.org/10.1111/j.0906-6705.2006.00409.x
- Gu M, Guan J, Zhao L, et al (2013). Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma. Int J Clin Exp Pathol, 6, 1132-7.
- Hou YQ, Fan LY, Tu XQ, et al (2004). Expression of extracellular matrix protein 1 in tumors and its significance. Academic J Second Military Medical University, 25, 1314-6.
- Lee KM, Nam K, Oh S, et al (2014). Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor-signaling. Breast Cancer Res, 16, 479. https://doi.org/10.1186/s13058-014-0479-6
- Kum RO, Ozcan M, Baklaci D,et al (2014). Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions. Asian Pac J Cancer Prev, 15, 7351-5. https://doi.org/10.7314/APJCP.2014.15.17.7351
- Lal G, Hashimi S, Smith BJ, et al (2009). Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa. Ann Surg Oncol, 16, 2280-7. https://doi.org/10.1245/s10434-009-0533-2
- Mathieu E, Meheus L, Raymackers J, et al (1994). Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res, 9, 903-13.
- Markou K, Christoforidou A, Karasmanis I, et al (2013). Laryngeal cancer: epidemiological data from Νorthern Greece and review of the literature. Hippokratia, 17, 313-8.
- Meng FS, Gao S, Xu Q, et al (2013). Study on the expression of Caspase-3 protein in laryngeal squamous cell carcinoma and its comparative relationship with cell apoptosis of laryngeal carcinoma. J Clin Experimental Medicine, 12, 258-60.
- Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41. https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
- Sercu S, Zhang L, Merregaert J (2008). The extracellular matrix protein 1: its molecular interaction and implication in tumor progression. Cancer Invest, 26, 375-84. https://doi.org/10.1080/07357900701788148
- Wu Q, Li X, Yang H, et al (2014). Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer. World J Surg Oncol, 12, 132. https://doi.org/10.1186/1477-7819-12-132
- Wu QW, She HQ, Liang J, et al (2012). Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. BMC Cancer, 12, 47. https://doi.org/10.1186/1471-2407-12-47
- Yang A, Kaghad M, Wang Y, et al (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell, 2, 305-16. https://doi.org/10.1016/S1097-2765(00)80275-0
- Zhu XJ, Liu J, Xu XY, et al (2014). Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. Mol Med Rep, 9, 2283-92.
Cited by
- Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases vol.34, pp.1, 2017, https://doi.org/10.1007/s10585-016-9827-5